SAN

79.29

+2.36%↑

UCB

251

+0.36%↑

SHL.DE

36.94

+0.52%↑

ARGX

591

+1.2%↑

VIE

32.39

+2.96%↑

SAN

79.29

+2.36%↑

UCB

251

+0.36%↑

SHL.DE

36.94

+0.52%↑

ARGX

591

+1.2%↑

VIE

32.39

+2.96%↑

SAN

79.29

+2.36%↑

UCB

251

+0.36%↑

SHL.DE

36.94

+0.52%↑

ARGX

591

+1.2%↑

VIE

32.39

+2.96%↑

SAN

79.29

+2.36%↑

UCB

251

+0.36%↑

SHL.DE

36.94

+0.52%↑

ARGX

591

+1.2%↑

VIE

32.39

+2.96%↑

SAN

79.29

+2.36%↑

UCB

251

+0.36%↑

SHL.DE

36.94

+0.52%↑

ARGX

591

+1.2%↑

VIE

32.39

+2.96%↑

Search

ICADE.

Open

SectorHealthcare

19.5 1.19

Overview

Share price change

24h

Current

Min

19.11

Max

19.6

Key metrics

By Trading Economics

Income

60M

-31M

Sales

84M

707M

EPS

-0.41

Profit margin

-4.427

Employees

983

EBITDA

-152M

-14M

Recommendations

By TipRanks

Recommendations

Strong Sell

12 Months Forecast

+2.96% upside

Market Stats

By TradingEconomics

Market Cap

-132M

1.5B

Previous open

18.31

Previous close

19.5

News Sentiment

By Acuity

50%

50%

171 / 350 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

ICADE. Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 mar 2026, 18:58 UTC

Major Market Movers

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24 mar 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24 mar 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24 mar 2026, 23:33 UTC

Market Talk
Major News Events

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24 mar 2026, 23:16 UTC

Market Talk

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24 mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24 mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24 mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24 mar 2026, 21:44 UTC

Market Talk

Global Equities Roundup: Market Talk

24 mar 2026, 21:44 UTC

Market Talk

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24 mar 2026, 20:59 UTC

Earnings

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24 mar 2026, 20:58 UTC

Major News Events

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24 mar 2026, 20:50 UTC

Market Talk
Major News Events

Energy & Utilities Roundup: Market Talk

24 mar 2026, 20:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

24 mar 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

24 mar 2026, 20:25 UTC

Earnings

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24 mar 2026, 20:15 UTC

Market Talk
Major News Events

Global Commodities Roundup: Market Talk

24 mar 2026, 20:10 UTC

Market Talk

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24 mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Sales $378.7M >WOR

24 mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Adj EPS 98c >WOR

24 mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q EPS 92c >WOR

24 mar 2026, 19:25 UTC

Market Talk
Major News Events

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24 mar 2026, 19:06 UTC

Market Talk
Major News Events

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24 mar 2026, 18:51 UTC

Market Talk
Major News Events

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24 mar 2026, 18:40 UTC

Market Talk
Major News Events

Global Forex and Fixed Income Roundup: Market Talk

24 mar 2026, 18:40 UTC

Market Talk
Major News Events

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24 mar 2026, 18:34 UTC

Major News Events

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24 mar 2026, 18:27 UTC

Market Talk

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24 mar 2026, 18:21 UTC

Market Talk
Major News Events

Silver Snaps 9-Session Losing Streak -- Market Talk

24 mar 2026, 18:00 UTC

Acquisitions, Mergers, Takeovers

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Peer Comparison

Price change

ICADE. Forecast

Price Target

By TipRanks

2.96% upside

12 Months Forecast

Average 19.82 EUR  2.96%

High 25 EUR

Low 17.1 EUR

Based on 5 Wall Street analysts offering 12 month price targets forICADE. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Sell

5 ratings

0

Buy

1

Hold

4

Sell

Technical Score

By Trading Central

21.04 / 21.4Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

171 / 350 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ICADE.

Icade is a full-service real estate company with expertise in both commercial property investment (portfolio worth "6.8bn on a full consolidation basis as of 12/31/2023) and property development (2023 economic revenue of "1.3bn) that operates throughout France. Icade has forged longterm partnerships to respond to emerging trends in the industry. It has made climate issues and the preservation of biodiversity central to its business model to reinvent real estate and contribute to more sustainable cities. It is listed as a "SIIC" on Euronext Paris and its leading shareholder is the Caisse des Dépôts group.
help-icon Live chat